These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31479731)

  • 21. Design, preparation and characterization of pH-responsive prodrug micelles with hydrolyzable anhydride linkages for controlled drug delivery.
    Seetharaman G; Kallar AR; Vijayan VM; Muthu J; Selvam S
    J Colloid Interface Sci; 2017 Apr; 492():61-72. PubMed ID: 28068545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiolytically cleavable dithiobenzyl urethane-linked polymer-protein conjugates as macromolecular prodrugs: reversible PEGylation of proteins.
    Zalipsky S; Mullah N; Engbers C; Hutchins MU; Kiwan R
    Bioconjug Chem; 2007; 18(6):1869-78. PubMed ID: 17935288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines.
    Rinaldi A; Caraffi R; Grazioli MV; Oddone N; Giardino L; Tosi G; Vandelli MA; Calzà L; Ruozi B; Duskey JT
    Polymers (Basel); 2022 Feb; 14(4):. PubMed ID: 35215600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II).
    Xiao H; Qi R; Liu S; Hu X; Duan T; Zheng Y; Huang Y; Jing X
    Biomaterials; 2011 Oct; 32(30):7732-9. PubMed ID: 21783244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Supplied Reactive Oxygen Species-Responsive Mitoxantrone Polyprodrug for Chemosensitization-Enhanced Chemotherapy under Moderate Hyperthermia.
    Zhang H; Wang J; Wu R; Zheng B; Sang Y; Wang B; Song L; Hu Y; Ma X
    Adv Healthc Mater; 2024 May; 13(12):e2303631. PubMed ID: 38278138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy-Controllable Chemotherapy from Reactive Oxygen Species-Responsive Polymeric Nanoparticles for Effective Local Dual Modality Treatment of Malignant Tumors.
    Liu TI; Yang YC; Chiang WH; Hung CK; Tsai YC; Chiang CS; Lo CL; Chiu HC
    Biomacromolecules; 2018 Sep; 19(9):3825-3839. PubMed ID: 30044907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive Oxygen Species Responsive Naturally Occurring Phenolic-Based Polymeric Prodrug.
    Berwin Singh SV; Adam AG; Tripathy N; Lee D; Khang G
    Adv Exp Med Biol; 2018; 1078():291-301. PubMed ID: 30357629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies.
    Vasvani S; Vasukutty A; Bardhan R; Park IK; Uthaman S
    Biomater Sci; 2024 Aug; 12(17):4335-4353. PubMed ID: 39041781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic iminoboronate-based polymersomes with a Cu(ii)-mediated Fenton reaction-enhanced ROS-response.
    Cheng R; Li G; Fan L; Jiang J; Zhao Y
    Chem Commun (Camb); 2020 Oct; 56(81):12246-12249. PubMed ID: 32929426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy.
    Meng H; Zou Y; Zhong P; Meng F; Zhang J; Cheng R; Zhong Z
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28464449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
    Peng X; Gandhi V
    Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Reactive (1)O2 - Responsive Combined Treatment System of Photodynamic and Chemotherapy for Cancer.
    Wang X; Meng G; Zhang S; Liu X
    Sci Rep; 2016 Jul; 6():29911. PubMed ID: 27443831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy.
    Zong Q; Xiao X; Li J; Yuan Y
    Biomater Sci; 2022 Jul; 10(15):4228-4234. PubMed ID: 35758299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, self-assembly and drug release behaviors of a bottlebrush polymer-HCPT prodrug for tumor chemotherapy.
    Lv F; Liu D; Cong H; Shen Y; Yu B
    Colloids Surf B Biointerfaces; 2019 Sep; 181():278-284. PubMed ID: 31154138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.